scholarly article | Q13442814 |
P50 | author | Ryan C Middleton | Q96195387 |
P2093 | author name string | Eduardo Marbán | |
Xuan Xu | |||
Mario Fournier | |||
Michael I Lewis | |||
P2860 | cites work | Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex | Q48155147 |
Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. | Q48414650 | ||
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. | Q51688048 | ||
Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction | Q57374670 | ||
Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats | Q61712109 | ||
Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension | Q61895176 | ||
Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole | Q68628023 | ||
Development of Crotalaria pulmonary hypertension: hemodynamic and structural study | Q70534991 | ||
Molecular pathogenesis of pulmonary arterial hypertension | Q24634317 | ||
Intrapericardial Delivery of Cardiosphere-Derived Cells: An Immunological Study in a Clinically Relevant Large Animal Model | Q28550109 | ||
Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension | Q28553086 | ||
Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension | Q28575888 | ||
Validation of contrast-enhanced magnetic resonance imaging to monitor regenerative efficacy after cell therapy in a porcine model of convalescent myocardial infarction | Q30570123 | ||
Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension | Q33593640 | ||
Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension | Q33898213 | ||
Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. | Q35050037 | ||
Therapeutic efficacy of cardiosphere-derived cells in a transgenic mouse model of non-ischaemic dilated cardiomyopathy | Q35203566 | ||
Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells | Q35666637 | ||
Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells | Q35799278 | ||
Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction | Q36040528 | ||
Fibroblasts Rendered Antifibrotic, Antiapoptotic, and Angiogenic by Priming With Cardiosphere-Derived Extracellular Membrane Vesicles | Q36121826 | ||
Modern age pathology of pulmonary arterial hypertension | Q37457479 | ||
Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. | Q37596193 | ||
Targeted delivery of genes to endothelial cells and cell- and gene-based therapy in pulmonary vascular diseases | Q38165146 | ||
Endothelial-like progenitor cells engineered to produce prostacyclin rescue monocrotaline-induced pulmonary arterial hypertension and provide right ventricle benefits | Q38488215 | ||
Challenges and opportunities in treating inflammation associated with pulmonary hypertension | Q38812727 | ||
Five-Year outcomes of patients enrolled in the REVEAL Registry | Q38996624 | ||
Cardiosphere-derived cells reverse heart failure with preserved ejection fraction (HFpEF) in rats by decreasing fibrosis and inflammation | Q40286144 | ||
Exosomes as critical agents of cardiac regeneration triggered by cell therapy. | Q40477633 | ||
Isolation and expansion of functionally-competent cardiac progenitor cells directly from heart biopsies | Q41061514 | ||
Progressive endothelial cell damage in an inflammatory model of pulmonary hypertension | Q43175522 | ||
Mesenchymal stem cell-based prostacyclin synthase gene therapy for pulmonary hypertension rats | Q43259343 | ||
Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats | Q44575160 | ||
Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy | Q44682915 | ||
Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease | Q45251410 | ||
Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease | Q46157334 | ||
Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry | Q46954401 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e0183557 | |
P577 | publication date | 2017-08-24 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Therapeutic benefits of intravenous cardiosphere-derived cell therapy in rats with pulmonary hypertension | |
P478 | volume | 12 |
Q94603780 | Allogeneic cardiosphere-derived cells (CAP-1002) in critically ill COVID-19 patients: compassionate-use case series |
Q61810177 | Clinical trial design and new therapies for pulmonary arterial hypertension |
Q64076884 | Disease-modifying bioactivity of intravenous cardiosphere-derived cells and exosomes in mdx mice |
Q90473072 | Infant cardiosphere-derived cells exhibit non-durable heart protection in dilated cardiomyopathy rats |
Q64040079 | Regenerative cell therapy for pulmonary arterial hypertension in animal models: a systematic review |
Search more.